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Patient summary
In some instances pregnancy is difficult to achieve without help. Assisted reproduction refers to the techniques and interventions used to help such individuals conceive and includes techniques such as in vitro fertilization (IVF). Some forms of assisted reproduction push the ovaries of the female to produce one or more eggs for this process. This is known as ovarian stimulation.
Introduction
A number of medications may be used for both ovulation induction (the production of a single mature follicle) and controlled ovarian hyperstimulation (the production of multiple mature follicles) including selective estrogen receptor modulators (SERMs), metformin, aromatase inhibitors, gonadotrophins, dopamine agonists and pulsatile gonadotrophin releasing hormone (GnRH).
3. Discussion 3.1 What are the considerations when intending to stimulate ovarian follicular development ? It is essential to perform an appropriate assessment prior to embarking on any therapy, including appropriate history, examination and investigations, that focus on the diagnosis, any preventable and correctible factors and suitability for pregnancy. Pre-pregnancy investigations such as a Pap smear (in accordance with local screening guidelines) appropriate pre-pregnancy vaccinations and advice on pre-conceptual folate and life style factors should be provided. RANZCOG advises that known and possible complications of ovarian stimulation should be discussed, including the risk of multiple pregnancy and ovarian hyperstimulation syndrome. Patients should be aware that there is no evidence to support any adverse effects on long term ovarian function or reproductive neoplasia (see below).
3.2
Is ovarian stimulation appropriate in women with a BMI greater than 35? A Body Mass Index (BMI) greater than or equal to 35 is a recognised risk factor in pregnancy and delivery and should be regarded as a contraindication to assisted fertility.
It is inappropriate to recommend ovarian stimulation (including IVF) as part of first line therapy in the female with a BMI >35 unless there are exceptional circumstances. Ovarian stimulation in these circumstances should be deferred until appropriate weight loss by appropriate measures (e.g. diet, exercise, bariatric surgery, etc.) has occurred. This is expected to improve general health, may restore normal ovulatory function and enhance pregnancy outcome.
3.3
Is there an increased ovarian cancer risk following ovarian stimulation? Results from currently available studies show that ovarian stimulation does not appear to be associated with an increased incidence of cancer, but continuing research and data analysis is necessary. Ovarian, breast and uterine cancers are known to be more common in women who have not had children.
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